04-04-2026 10:53 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Natco Pharma Ltd.
Change Company   
BSE Code 524816
ISIN Demat INE987B01026
Book Value 467.76
NSE Code NATCOPHARM
Dividend Yield % 0.58
Market Cap 184098.08
P/E 12.27
EPS 83.75
Face Value 2  
24-Mar-2026 Scheme of Arrangement
20-Mar-2026 NATCO Pharma informs about press release
06-Mar-2026 NATCO Pharma informs about analyst meet
04-Mar-2026 Natco Pharma launches Pomalidomide capsules with ...
04-Mar-2026 Natco Pharma rises on launching Pomalidomide caps...
25-Feb-2026 Natco Pharma informs about clarification on volum...
25-Feb-2026 Clarification sought from Natco Pharma Ltd
24-Feb-2026 Clarification sought from Natco Pharma Ltd
16-Feb-2026 Natco Pharma jumps on getting CDSCO’s approval fo...
14-Feb-2026 Natco Pharma gets CDSCO’s approval for Semaglutid...
13-Feb-2026 Natco Pharma gets EIR for API division in Chennai
13-Feb-2026 NATCO Pharma informs about press release
12-Feb-2026 Natco Pharma gets nod to incorporate wholly owned...
12-Feb-2026 Natco Pharma reports 14% rise in Q3 consolidated ...
12-Feb-2026 Natco Pharma informs about un-audited financial r...
Page 1 of 3
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.